These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19071997)

  • 1. Causal inference in randomized experiments with mediational processes.
    Jo B
    Psychol Methods; 2008 Dec; 13(4):314-36. PubMed ID: 19071997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond total treatment effects in randomised controlled trials: Baseline measurement of intermediate outcomes needed to reduce confounding in mediation investigations.
    Landau S; Emsley R; Dunn G
    Clin Trials; 2018 Jun; 15(3):247-256. PubMed ID: 29552919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.
    Murray EJ; Robins JM; Seage GR; Freedberg KA; Hernán MA
    Am J Epidemiol; 2017 Jul; 186(2):131-142. PubMed ID: 28838064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding.
    Taguri M; Chiba Y
    Stat Med; 2015 Jan; 34(1):131-44. PubMed ID: 25312003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of principal scores to estimate the marginal compliers causal effect of an intervention.
    Porcher R; Leyrat C; Baron G; Giraudeau B; Boutron I
    Stat Med; 2016 Feb; 35(5):752-67. PubMed ID: 26381261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying treatment responders using counterfactual modeling and potential outcomes.
    Porcher R; Jacot J; Wunder JS; Biau DJ
    Stat Methods Med Res; 2019; 28(10-11):3346-3362. PubMed ID: 30298794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical approaches for enhancing causal interpretation of the M to Y relation in mediation analysis.
    MacKinnon DP; Pirlott AG
    Pers Soc Psychol Rev; 2015 Feb; 19(1):30-43. PubMed ID: 25063043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.
    Alonso A; Van der Elst W; Molenberghs G; Buyse M; Burzykowski T
    Biometrics; 2016 Sep; 72(3):669-77. PubMed ID: 26864244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penalized regression procedures for variable selection in the potential outcomes framework.
    Ghosh D; Zhu Y; Coffman DL
    Stat Med; 2015 May; 34(10):1645-58. PubMed ID: 25628185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal stratification--a goal or a tool?
    Pearl J
    Int J Biostat; 2011 Mar; 7(1):20. PubMed ID: 21556288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exact confidence intervals for the average causal effect on a binary outcome.
    Li X; Ding P
    Stat Med; 2016 Mar; 35(6):957-60. PubMed ID: 26833798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.
    Conlon A; Taylor J; Li Y; Diaz-Ordaz K; Elliott M
    Stat Med; 2017 Nov; 36(27):4243-4265. PubMed ID: 28786131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation.
    Carpenter JR; Roger JH; Kenward MG
    J Biopharm Stat; 2013; 23(6):1352-71. PubMed ID: 24138436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A refreshing account of principal stratification.
    Mealli F; Mattei A
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instruments and bounds for causal effects under the monotonic selection assumption.
    Taguri M; Chiba Y
    Int J Biostat; 2012 Aug; 8(1):24. PubMed ID: 22944723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.